Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
Authors
Keywords
Oligometastases, Stereotactic radiotherapy, Quality of life, Cancer, Survival
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-19
DOI
10.1186/s12885-019-5977-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
- (2019) David A Palma et al. LANCET
- Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
- (2018) Samra Turajlic et al. CELL
- Role of daily plan adaptation in MR-guided stereotactic ablative radiotherapy for adrenal metastases
- (2018) M.A. Palacios et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MR-guided gated stereotactic radiotherapy delivery for lung, adrenal and pancreatic tumors: a geometric analysis
- (2018) John R. van Sörnsen de Koste et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches
- (2018) H. Tekatli et al. LUNG CANCER
- Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis
- (2018) Julian C. Hong et al. PLoS One
- Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
- (2018) Puneeth Iyengar et al. JAMA Oncology
- The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “indolent” stage IV disease (Stage IVindolent).
- (2018) Andrew A. Davis et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial
- (2018) D.A. Palma et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials
- (2017) Timothy A. Ritter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
- (2017) Theo Ruers et al. JNCI-Journal of the National Cancer Institute
- Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
- (2017) Louise van der Weyden et al. NATURE
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer
- (2017) O. Bohoudi et al. RADIOTHERAPY AND ONCOLOGY
- Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
- (2017) Theo Ruers et al. JNCI-Journal of the National Cancer Institute
- Stereotactic Body Radiotherapy for Oligometastasis
- (2016) Rohann J.M. Correa et al. CANCER JOURNAL
- Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
- (2016) Daniel R Gomez et al. LANCET ONCOLOGY
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- New Strategies in Stereotactic Radiotherapy for Oligometastases
- (2015) D. A. Palma et al. CLINICAL CANCER RESEARCH
- 14q32-encoded microRNAs mediate an oligometastatic phenotype
- (2015) Abhineet Uppal et al. Oncotarget
- The oligometastatic state—separating truth from wishful thinking
- (2014) David A. Palma et al. Nature Reviews Clinical Oncology
- Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery
- (2013) Paul Rava et al. JOURNAL OF NEUROSURGERY
- Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
- (2012) T. Ruers et al. ANNALS OF ONCOLOGY
- Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
- (2012) David A Palma et al. BMC CANCER
- Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs
- (2012) Yves A. Lussier et al. PLoS One
- MicroRNA Expression Characterizes Oligometastasis(es)
- (2011) Yves A. Lussier et al. PLoS One
- Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
- (2011) Praveena Cheruvu et al. Radiation Oncology
- Lung metastasectomy in colorectal cancer: Is this surgery effective in prolonging life?
- (2010) John PRIMROSE et al. RESPIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started